Samson-Med

Samson-Med is a prominent Russian biopharmaceutical company with a history dating back to 1937, specializing in the development and production of organotherapeutic drugs. The company is a leader in the extraction and purification of biologically active peptides and proteins from animal tissues, producing well-known brands such as Samprost for urological health. Samson-Med operates a modern, full-cycle manufacturing facility in St. Petersburg that complies with international GMP standards, enabling the production of both active pharmaceutical ingredients and finished dosage forms. In addition to its proprietary portfolio, the company serves as a contract manufacturing organization (CMO) for domestic and international partners. Its research and development efforts focus on expanding its pipeline in urology, gastroenterology, and immunology.